Improving HIV Prevention Among Heterosexual Men Seeking STI Services in Malawi

NCT ID: NCT06200545

Last Updated: 2025-12-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

199 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-04-02

Study Completion Date

2025-07-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To evaluate the potential benefit(s), acceptability, and associated costs of a systems navigator-delivered HIV prevention intervention in promoting and supporting persistent use of evidence-based HIV pre-exposure prophylaxis (PrEP) among heterosexual men receiving care for sexually transmitted infections (STIs) in Lilongwe, Malawi.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

HIV Infection Sexually Transmitted Infections Pre-exposure Prophylaxis Systems Navigation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Standard of care PrEP services

Standard of care (SOC) PrEP services include PrEP eligibility assessment, rapid HIV antibody testing prior to provision and/or refill of PrEP, and PrEP follow-up with a PrEP nurse in accordance with contemporary PrEP guidelines. Specifically, SOC services do not generally include point of contact STI testing (with the exception of rapid syphilis and Hepatitis B antigen testing, if kits are available, at PrEP initiation) nor tracing for missed PrEP visits. Participants randomized to the SOC condition will receive these standard PrEP services.

Group Type ACTIVE_COMPARATOR

PrEP eligibility assessment

Intervention Type OTHER

PrEP eligibility assessment

Rapid HIV antibody testing prior to provision and/or refill of PrEP

Intervention Type DIAGNOSTIC_TEST

Rapid HIV antibody testing prior to provision and/or refill of PrEP

PrEP follow-up with a PrEP nurse in accordance with contemporary PrEP guidelines

Intervention Type OTHER

PrEP follow-up with a PrEP nurse in accordance with contemporary PrEP guidelines

Intervention package PrEP services

The intervention package is integrated into PrEP visits and includes evaluation of barriers and facilitators to ongoing PrEP use, point of contact STI testing to inform counseling regarding ongoing PrEP care engagement, tracing for any missed PrEP visits, and offering a PrEP "restart" kit for men who choose to discontinue PrEP during the follow-up period. Recognizing increasingly cyclical PrEP use patterns, navigators serve as a direct entry point to retain or re-engage participants in HIV prevention care.

Group Type EXPERIMENTAL

PrEP eligibility assessment

Intervention Type OTHER

PrEP eligibility assessment

Rapid HIV antibody testing prior to provision and/or refill of PrEP

Intervention Type DIAGNOSTIC_TEST

Rapid HIV antibody testing prior to provision and/or refill of PrEP

PrEP follow-up with a PrEP nurse in accordance with contemporary PrEP guidelines

Intervention Type OTHER

PrEP follow-up with a PrEP nurse in accordance with contemporary PrEP guidelines

Evaluation of barriers and facilitators to ongoing PrEP use

Intervention Type BEHAVIORAL

Evaluation of barriers and facilitators to ongoing PrEP use

Point of contact STI testing to inform counseling regarding ongoing PrEP care engagement

Intervention Type OTHER

Point of contact STI testing to inform counseling regarding ongoing PrEP care engagement

Tracing for any missed PrEP visits

Intervention Type OTHER

Tracing for any missed PrEP visits

Offering a PrEP "restart" kit for men who choose to discontinue PrEP during the follow-up period

Intervention Type OTHER

Offering a PrEP "restart" kit for men who choose to discontinue PrEP during the follow-up period

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

PrEP eligibility assessment

PrEP eligibility assessment

Intervention Type OTHER

Rapid HIV antibody testing prior to provision and/or refill of PrEP

Rapid HIV antibody testing prior to provision and/or refill of PrEP

Intervention Type DIAGNOSTIC_TEST

PrEP follow-up with a PrEP nurse in accordance with contemporary PrEP guidelines

PrEP follow-up with a PrEP nurse in accordance with contemporary PrEP guidelines

Intervention Type OTHER

Evaluation of barriers and facilitators to ongoing PrEP use

Evaluation of barriers and facilitators to ongoing PrEP use

Intervention Type BEHAVIORAL

Point of contact STI testing to inform counseling regarding ongoing PrEP care engagement

Point of contact STI testing to inform counseling regarding ongoing PrEP care engagement

Intervention Type OTHER

Tracing for any missed PrEP visits

Tracing for any missed PrEP visits

Intervention Type OTHER

Offering a PrEP "restart" kit for men who choose to discontinue PrEP during the follow-up period

Offering a PrEP "restart" kit for men who choose to discontinue PrEP during the follow-up period

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Adult and adolescent men who meet all of the following criteria are eligible for inclusion in this study as a participant initiating PrEP:

* Age ≥18 years, or age 15-17 (with assent and parent/guardian consent)
* Able to provide informed consent
* No plans to move outside study area for at least 26 weeks after study enrollment
* Willing to provide contact/locator information, including phone number, to facilitate tracing
* Willing to participate in study activities, including specimen collection
* Willing to participate in study activities, including systems navigation, counseling, and point of contact STI testing
* Sought STI clinic services within 7 days of enrollment
* Initiated on PrEP at STI clinic within 7 days of enrollment
* Reports at least one female sex partner in the 6 months prior to enrollment
* Self-identifies as heterosexual
2. Individuals who meet all of the following criteria are eligible for inclusion in this study as other key stakeholders:

* Age ≥18 years at the enrollment visit
* Able to provide informed consent
* Involved in provision of clinical service navigation, systems navigation, STI or HIV care or prevention (including clinic management or oversight), or development of HIV prevention policy or programs at local or national level

Exclusion Criteria

1. Adult and adolescent men who meet any of the following criteria are ineligible for inclusion in this study as a participant initiating PrEP:

* Appearance of psychological disturbance or cognitive impairment that would limit the ability to understand study procedures, as determined by the investigators
* Any other condition that, in the opinion of the investigators, would make participation in the study unsafe, or otherwise interfere with the conduct of the study
* Current participation in any HIV prevention study or other study considered to interfere the interpretation of study outcomes.
2. Individuals who meet any of the following criteria are ineligible for inclusion in this study as other key stakeholder:

* Appearance of psychological disturbance or cognitive impairment that would limit the ability to understand study procedures, as determined by the investigators
* Any other condition that, in the opinion of the investigators, would make participation in the study unsafe, or otherwise interfere with the study activities
Minimum Eligible Age

15 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

HIV Prevention Trials Network

NETWORK

Sponsor Role lead

Division of AIDS, US National Institute of Allergy and Infectious Diseases

UNKNOWN

Sponsor Role collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

Sponsor Role collaborator

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Sarah Rutstein, MD, PhD

Role: STUDY_CHAIR

University of North Carolina, Chapel Hill

Mitch Matoga, MBBS, MSc

Role: STUDY_CHAIR

UNC Project Malawi

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Malawi CRS

Lilongwe, , Malawi

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Malawi

References

Explore related publications, articles, or registry entries linked to this study.

Rutstein SE, Limarzi-Klyn L, Chen JS, Agyei YO, Ahmed S, Bell I, Cohen M, Fogel JM, Go V, Haines D, Hamilton EL, Hoffman IF, Hosseinipour MC, Marzinke MA, Miller WC, Mukatipa M, Pulerwitz J, Spiegel HML, Ye T, Matoga M. Improving HIV Prevention Among Heterosexual Men Seeking Sexually Transmitted Infection Services in Malawi: Protocol for a Type I Effectiveness-Implementation Hybrid Randomized Controlled Trial of Systems Navigator-Delivered Integrated Prevention Package (HPTN 112-NJIRA Study). JMIR Res Protoc. 2025 Jun 18;14:e72981. doi: 10.2196/72981.

Reference Type DERIVED
PMID: 40531570 (View on PubMed)

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Informed Consent Form

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

UM1AI068619-17

Identifier Type: NIH

Identifier Source: secondary_id

View Link

HPTN 112

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

HIV Prevention Among At-risk Latinos in the Heartland
NCT04563715 ENROLLING_BY_INVITATION NA
The Collaborative Care PrTNER Study
NCT06585631 RECRUITING NA
The Test-to-PrEP Study
NCT06927856 RECRUITING NA
Peer-driven Intervention on PrEP
NCT05161663 COMPLETED NA